文献速递神经肿瘤功能神经外科

复发性胶样囊肿的纯内镜移除:与原发性囊肿的对比研究

Endoscopic removal of recurrent colloid cysts.
PubMed 文献 · J Neurosurg · 2019-04-12

本研究回顾性比较了121例原发性胶样囊肿与10例复发性囊肿(共11个)的纯内镜移除效果。复发性囊肿组完全切除比例较低(90.9% vs 81.8%,p=0.296)、复发率较高(18.2% vs 2.5%,p=0.055),但差异无统计学意义;两组症状表现率无显著差异(p=0.749),原发性组术前脑积水比例显著更高(63.6% vs 18.2%,p=0.007)。结论认为纯内镜移除复发性胶样囊肿可行且与原发性囊肿同样安全,作者仍推荐在囊肿复发时行内镜移除。

要点

  • 纯内镜移除复发性胶样囊肿可行且安全,无术后即时并发症或新发致残。
  • 复发性囊肿组完全切除比例较低、复发率较高,但差异均无统计学意义。
  • 复发性囊肿组症状表现率较低,原发性组术前脑积水比例显著更高。

核心结论

  • 纯内镜移除复发性第三脑室胶样囊肿可行,且与原发性囊肿内镜移除同样安全。
  • 两组复发率差异无统计学意义。
  • 复发性囊肿组症状性表现比例低于原发性囊肿组。
  • 因完全切除率高且并发症极少,作者仍推荐在囊肿复发时行内镜移除。

研究设计与样本

  • 回顾性队列研究,比较复发性胶样囊肿与原发性胶样囊肿的纯内镜移除。
  • 共121例原发性囊肿患者和10例复发性囊肿患者(共11个复发性囊肿)接受纯内镜移除。
  • 分类变量采用Fisher精确检验,连续变量采用Mann-Whitney U检验。

主要发现

  • 原发性囊肿组术后复发或进展3例(2.5%),复发性囊肿组2例(18.2%)。
  • 随访期间症状性表现:复发性囊肿组6例(54.5%),原发性囊肿组75例(62%)(p=0.749)。
  • 复发性囊肿组2例(20%)出现第二次复发,平均间隔30个月(1例15个月、1例45个月)。
  • 其中1例在第二次切除后8年需第三次内镜移除。
  • 重复内镜手术后未观察到即时术后并发症或新发致残。

临床怎么用

  • 纯内镜入路可用于复发性第三脑室胶样囊肿的移除,安全性可接受。
  • 复发时再次内镜移除仍可考虑,因完全切除率高且并发症极少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Removal of colloid cysts of the third ventricle using a purely endoscopic method has been established as a safe and advantageous technique. It is hypothesized that endoscopic removal in recurrent cases might pose more technical challenges and result in less success. The objective of this study was to assess the feasibility and outcomes of using a purely endoscopic approach for the management of recurrent colloid cysts compared to primary cysts. METHODS: A retrospective cohort study was performed on patients who underwent purely endoscopic removal of their colloid cyst. Descriptive statistics were compared for patients undergoing surgery for a recurrent cyst and those for a control cohort undergoing surgery for a primary cyst. Bivariate analysis was conducted using a Fisher's exact test for categorical variables and Mann-Whitney U-test for continuous variables. RESULTS: In total, 121 patients had a primary colloid cyst endoscopically removed and 10 patients had a total of 11 recurrent cysts removed. Recurrence or progression after surgery occurred in 3 (2.5%) cases in the primary cyst group and 2 (18.2%) cases in the recurrent cyst group. Symptomatic presentation during the follow-up period occurred in 6 (54.5%) cases in the recurrent cyst group versus 75 (62%) cases in the primary cyst group (p = 0.749). Two patients (20%) in the recurrent group had a second recurrence in a mean period of 30 months (1 patient at 15 and 1 patient at 45 months). One of these patients required a tertiary endoscopic removal 8 years after the second resection. No immediate postoperative complications or new morbidities were observed after repeat endoscopic surgery. The authors' findings indicated a nonsignificant trend toward a higher recurrence rate (18.2% vs 2.5%, p = 0.055) and a decreased proportion of complete removal (90.9% vs 81.8%, p = 0.296) in the recurrent cyst group compared to the primary cyst group. However, a significantly higher rate of preoperative hydrocephalus was observed in the primary cyst group compared with the recurrent cyst group (63.6% vs 18.2%, p = 0.007). CONCLUSIONS: Purely endoscopic approaches for the removal of recurrent colloid cysts of the third ventricle are feasible and equally safe compared with endoscopic removal of primary cysts. The study's findings did not show a statistically significant difference in the rate of recurrence between the 2 groups. The proportion of patients with symptomatic cysts on presentation was lower in patients with recurrent cysts than in patients with primary cysts. Due to the high rate of complete removal with negligible morbidity, the authors continue to advocate for an endoscopic removal at the time of cyst recurrence.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lara-Reyna JJ, Uribe-Cardenas R, Perera I, et al. Endoscopic removal of recurrent colloid cysts. J Neurosurg. 2019. PMID: 30978688. doi:10.3171/2018.12.JNS181859

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。